lobbying_activities: 836540

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
836540	809a92eb-daba-48ea-9562-db013b8aaf66	Q3	MEHLMAN CONSULTING, INC.	284950	ABBOTT LABORATORIES	2009	third_quarter	PHA	Health care reform: H.R.3200, America's Affordable Health Choices Act and S.1679, Affordable Health Choice Act. Food & Drug Administration reforms; Medicare coverage and reimbursement. Follow on Biologics: H.R.1548, Pathway for Biosimilars Act.	HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2009-10-19T12:00:01-04:00